Your browser doesn't support javascript.
loading
Pharmacokinetic and Pharmacodynamic Properties and Tolerability of Single- and multiple-dose Once-daily Empagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, in Chinese Patients With Type 2 Diabetes Mellitus.
Zhao, Xia; Cui, Yimin; Zhao, Shuai; Lang, Benjamin; Broedl, Uli C; Salsali, Afshin; Pinnetti, Sabine; Macha, Sreeraj.
Afiliação
  • Zhao X; Peking University First Hospital, Beijing, People׳s Republic of China.
  • Cui Y; Peking University First Hospital, Beijing, People׳s Republic of China. Electronic address: cuiymzy@126.com.
  • Zhao S; Boehringer Ingelheim Corporation, Shanghai, People׳s Republic of China.
  • Lang B; Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany.
  • Broedl UC; Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany.
  • Salsali A; Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut, USA.
  • Pinnetti S; Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany.
  • Macha S; Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut, USA.
Clin Ther ; 37(7): 1493-502, 2015 Jul 01.
Article em En | MEDLINE | ID: mdl-26101175

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Diabetes Mellitus Tipo 2 / Glucosídeos / Hipoglicemiantes Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Ther Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Diabetes Mellitus Tipo 2 / Glucosídeos / Hipoglicemiantes Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Ther Ano de publicação: 2015 Tipo de documento: Article